Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease
Frank Martiniuk(Psychogenics (United States)), Paul H. Plötz(National Institutes of Health), Adra Mack(New York University), William J. Codd(Bellevue Hospital Center), Eleni Arvanitopoulos(Columbia University Irving Medical Center), Nina Raben(APT Therapeutics (United States)), Agnes Chen(Columbia University Irving Medical Center), Ying Chen(Soochow University), Phil Alcabes(NYU Langone Health), Bruce A. Hanna(Bellevue Hospital Center), William N. Rom(New York University)
American Journal of Medical Genetics
August 27, 1998
Cited by 214
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1.
|Proceedings of the National Academy of Sciences|1992|730
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395